Cargando…

Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.

Detalles Bibliográficos
Autores principales:	Millward, M. J., Cantwell, B. M., Dowsett, M., Carmichael, J., Harris, A. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972372/ https://www.ncbi.nlm.nih.gov/pubmed/1903951

Ejemplares similares

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1989)

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
por: Lind, M. J., et al.
Publicado: (1992)

High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1988)

Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects.
por: Crighton, I. L., et al.
Publicado: (1989)

ENDOCRINE RESPONSE TO AN ULTRA-MARATHON IN PRE- AND POST-MENOPAUSAL WOMEN
por: Copeland, J.L., et al.
Publicado: (2014)

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

Endocrinal metabolic regulation on the skeletal system in post-menopausal women
por: Thapa, Santosh, et al.
Publicado: (2022)

Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.
por: Philip, P. A., et al.
Publicado: (1993)

Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies
por: Velentzis, L S, et al.
Publicado: (2009)

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee.
por: Carmichael, J., et al.
Publicado: (1990)

The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
por: Dowsett, M, et al.
Publicado: (1999)

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia
por: Saiful Bahri, Athirah, et al.
Publicado: (2021)

Phase II study of gemcitabine in patients with advanced pancreatic cancer.
por: Carmichael, J., et al.
Publicado: (1996)

A Neuro-Vasculo-Endocrine Approach to Menopause
por: Kalra, Sanjay
Publicado: (2022)

The Effect of Ru on the Evolution of the γ′ Phase in Ni-Al-Ru Alloys
por: Wang, Shaoyang, et al.
Publicado: (2022)

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.
por: Millward, M. J., et al.
Publicado: (1993)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.
por: Thomas, H. V., et al.
Publicado: (1997)

A phase II trial of paclitaxel and epirubicin in advanced breast cancer
por: Rischin, D, et al.
Publicado: (2000)

Novel Unsymmetrical Ru(III) and Mixed-valence Ru(III)/Ru(II) Dinuclear Compounds Related to the Antimetastatic Ru(III) Drug NAMI-A
por: Serli, B., et al.
Publicado: (2001)

Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents
por: Agrawal, Amit, et al.
Publicado: (2006)

A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor.
por: Veale, D., et al.
Publicado: (1988)

Differences in Polysomnography Parameters of Women in the Post and Transitional Phases of Menopause
por: Dugral, Esra, et al.
Publicado: (2021)

Safety Assessment of Endocrine Disruption by Menopausal Health Functional Ingredients
por: Kang, Soyeon, et al.
Publicado: (2021)

Obesity in post menopausal women with a family history of breast cancer: prevalence and risk awareness
por: Begum, Parvin, et al.
Publicado: (2009)

Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer.
por: Harding, M. J., et al.
Publicado: (1988)

Self-assembly of Ru(4) and Ru(8) assemblies by coordination using organometallic Ru(II)(2) precursors: Synthesis, characterization and properties
por: Shanmugaraju, Sankarasekaran, et al.
Publicado: (2012)

Electrochemical data of polypyridine complexes of Ru(II)
por: van der Westhuizen, Deidré, et al.
Publicado: (2019)

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.
por: Bontenbal, M., et al.
Publicado: (1998)

Differential Genetic Basis for Pre-Menopausal and Post-Menopausal Salt-Sensitive Hypertension
por: Herrera, Victoria L. M., et al.
Publicado: (2012)

The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study
por: Donohoe, Fionán, et al.
Publicado: (2021)

A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1990)

Parity predicts biological age acceleration in post-menopausal, but not pre-menopausal, women
por: Shirazi, Talia N., et al.
Publicado: (2020)

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
por: Stein, R. C., et al.
Publicado: (1990)

Investigation of the Superlattice Phases Formed in Ta(72)Ru(28)
por: Carruthers, Alexander W., et al.
Publicado: (2023)

Aromatase inhibitors in post-menopausal endometriosis
por: Polyzos, Nikolaos P, et al.
Publicado: (2011)

Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes
por: Gałczyńska, Katarzyna, et al.
Publicado: (2020)

Post-Menopausal Hæmorrhage—Discussion
Publicado: (1933)

Ligand Substitution of Ru(II)–Alkylidenes to Ru(bpy)(3) (2+): Sequential Olefin Metathesis/Photoredox Catalysis
por: Gallhof, Malte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p2sc049a1ralj5pcfc00mup3i0